StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2023, năm kết thúc ngày Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Medicenna Therapeutics's operating cash flow for the twelve months ending Mar 31, 2022 was -C$23.58M. For fiscal 2022 it was -C$23.58M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2022Mar 31, 2022-C$23.58M–
FY2021Mar 31, 2021-C$15.31M–
FY2020Mar 31, 2020-C$5.42M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ1 2023Mar 31, 2023-C$12.66M–
Q4 FY2022CQ1 2022Mar 31, 2022-C$23.58M–
Q4 FY2021CQ1 2021Mar 31, 2021-C$15.31M–

More Medicenna Therapeutics figures

See a number that looks wrong?